Paul Kelly: The role of Space OAR Vue in modifying the risk of rectal side effects

Paul Kelly, Radiation Oncologist at Bon Secours Hospital Cork UPMC, Ireland  shared a post by Karen Molan, Senior Clinical Researcher at UPMC Ireland, on X, adding:

“Great to make a contribution to this prostate cancer radiotherapy SBRT clinical trial, the subject of which is the role of Boston Scientific EMEA – Urology Space OAR Vue in modifying the risk of rectal side effects.

Patients are never the barrier to clinical trial recruitment.”

Quoting Karen Molan:

“Trial Activity.
SABRE Trial Achievement
20 Patients recruited.”